← FDA DRUG APPROVALS

FDA ANDA · ANDA087385

TRIAMCINOLONE ACETONIDE

Sponsor: PADAGIS US

APPLICATION
ANDA087385
TYPE
ANDA
ORIGINAL APPROVAL
1981-11-05
LATEST ACTION
1999-03-26
ROUTE
TOPICAL
DOSAGE FORM
OINTMENT
MARKETING STATUS
Prescription

Products

TRIAMCINOLONE ACETONIDE · ReferencePrescription
TRIAMCINOLONE ACETONIDE 0.025% · OINTMENT · TOPICAL
TRIAMCINOLONE ACETONIDE · ReferencePrescription
TRIAMCINOLONE ACETONIDE 0.1% · OINTMENT · TOPICAL
TRIAMCINOLONE ACETONIDE · ReferencePrescription
TRIAMCINOLONE ACETONIDE 0.5% · OINTMENT · TOPICAL

Approval history

1999-03-26Manufacturing (CMC) · Supplement 15AP
1995-06-14Labeling · Supplement 13AP
1988-05-13Manufacturing (CMC) · Supplement 12AP
1986-09-23Manufacturing (CMC) · Supplement 10AP
1986-06-09Manufacturing (CMC) · Supplement 9AP
1986-04-28Manufacturing (CMC) · Supplement 3AP
1984-07-11Manufacturing (CMC) · Supplement 4AP
1981-11-05OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →